HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daidi Fan Selected Research

ginsenoside M1

9/2022A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma.
2/2022Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo.
1/2022Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism.
5/2021Inhibitory Effect of pH-Responsive Nanogel Encapsulating Ginsenoside CK against Lung Cancer.
5/2021Ginsenoside CK Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daidi Fan Research Topics

Disease

23Neoplasms (Cancer)
09/2022 - 01/2017
20Wounds and Injuries (Trauma)
11/2022 - 12/2017
18Inflammation (Inflammations)
11/2022 - 03/2014
5Hypoxia (Hypoxemia)
06/2022 - 05/2021
5Insulin Resistance
08/2021 - 01/2017
5Type 2 Diabetes Mellitus (MODY)
02/2021 - 06/2015
4Hepatocellular Carcinoma (Hepatoma)
09/2022 - 05/2021
4Neoplasm Metastasis (Metastasis)
06/2022 - 10/2021
3Lung Neoplasms (Lung Cancer)
06/2022 - 01/2019
3Infections
01/2022 - 07/2020
3Breast Neoplasms (Breast Cancer)
01/2020 - 01/2018
2Stomach Neoplasms (Stomach Cancer)
04/2022 - 10/2019
2Adenocarcinoma of Lung
02/2022 - 01/2020
2Hyperthermia
02/2022 - 01/2015
2Bacterial Infections (Bacterial Infection)
01/2022 - 01/2022
2Triple Negative Breast Neoplasms
01/2022 - 01/2019
2Necrosis
09/2021 - 04/2018
2Hyperglycemia
02/2021 - 05/2019
2Burns
01/2021 - 07/2020
2Dysbiosis
01/2021 - 05/2020
2Hemolysis
09/2020 - 07/2020
2Stomach Ulcer (Gastric Ulcer)
05/2020 - 04/2017
2Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2019
2Anemia
07/2019 - 04/2018
2Osteoporosis
12/2018 - 02/2018
2Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2017 - 03/2016
1Hemorrhage
08/2022
1Non-alcoholic Fatty Liver Disease
02/2022
1Body Weight (Weight, Body)
02/2022
1Tissue Adhesions
01/2022

Drug/Important Bio-Agent (IBA)

22HydrogelsIBA
11/2022 - 03/2014
13CollagenIBA
10/2021 - 03/2010
11GinsenosidesIBA
06/2022 - 01/2017
11ginsenoside Rk3IBA
10/2021 - 10/2017
9Glucose (Dextrose)FDA LinkGeneric
11/2022 - 03/2010
8Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2015
8Pharmaceutical PreparationsIBA
08/2020 - 01/2018
7ginsenoside Rh4IBA
04/2022 - 01/2018
6ginsenoside Rg5IBA
08/2021 - 11/2018
6SaponinsIBA
10/2019 - 01/2017
5ginsenoside M1IBA
09/2022 - 05/2021
4ginsenoside Rk1IBA
04/2022 - 01/2019
4AntioxidantsIBA
03/2022 - 10/2021
4Streptozocin (Streptozotocin)FDA Link
02/2021 - 01/2017
3Insulin (Novolin)FDA Link
11/2022 - 05/2019
3Polysaccharides (Glycans)IBA
08/2022 - 07/2020
3CytokinesIBA
10/2021 - 05/2021
3Biological ProductsIBA
08/2021 - 10/2018
3Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 07/2019
3Hypoglycemic Agents (Hypoglycemics)IBA
06/2020 - 06/2015
3Acetic Acid (Vinegar)FDA LinkGeneric
05/2020 - 03/2010
3Antineoplastic Agents (Antineoplastics)IBA
08/2019 - 11/2018
2polydopamineIBA
08/2022 - 02/2022
2Glutamine (L-Glutamine)FDA Link
04/2022 - 01/2022
2Reactive Nitrogen SpeciesIBA
03/2022 - 01/2022
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 01/2022
2CatalaseIBA
03/2022 - 01/2022
2Peroxidase (Myeloperoxidase)IBA
02/2022 - 01/2022
2catechol (pyrocatechol)IBA
02/2022 - 01/2021
2Oxygen (Dioxygen)IBA
02/2022 - 01/2022
2Tannic AcidFDA Link
11/2021 - 09/2021
2GlycogenIBA
08/2021 - 11/2020
2eurocristatineIBA
11/2020 - 06/2020
2protopanaxadiolIBA
10/2019 - 01/2017
2protopanaxatriolIBA
07/2019 - 01/2017
2Biocompatible Materials (Biomaterials)IBA
07/2019 - 06/2009
2IronIBA
01/2017 - 03/2016
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2022
1Celecoxib (Celebrex)FDA Link
11/2022
1Transcription Factors (Transcription Factor)IBA
09/2022
1Dextrans (Dextran)FDA Link
08/2022
1CryogelsIBA
08/2022
1Hemostatics (Antihemorrhagics)IBA
08/2022
1paramylonIBA
08/2022
1ginsenoside Rh3IBA
06/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2022
1Small Interfering RNA (siRNA)IBA
06/2022
1U 0126 (UO 126)IBA
06/2022
1LipidsIBA
02/2022
1FructoseIBA
02/2022
1Hydroxyl RadicalIBA
02/2022
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2022
1MXeneIBA
01/2022
1EstersIBA
01/2022
1Superoxide DismutaseIBA
01/2022
1AnionsIBA
01/2022
1Superoxides (Superoxide)IBA
01/2022
1EnzymesIBA
01/2022
1BoronIBA
01/2022
1polyacrylamideIBA
11/2021
1Sepharose (Agarose)IBA
11/2021
1AgarIBA
11/2021
1boraxIBA
11/2021
1EicosanoidsIBA
10/2021
1Dinoprostone (PGE2)FDA Link
10/2021
1Epoxide HydrolasesIBA
10/2021

Therapy/Procedure

9Therapeutics
09/2022 - 01/2018
2Drug Therapy (Chemotherapy)
10/2021 - 11/2018
1Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2022
1Adjuvant Chemotherapy
04/2022